Current Status of Novel Agents for the Treatment of B Cell
Malignancies: What’s Coming Next?

B. Bauvois; Mariana Tannoury; Delphine Garnier; Santos A. Susin

Journal Articles (Review Article) Cancers Year : 2022

Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?

(1) , , ,

1

B. Bauvois

Function : Correspondent author
PersonId : 182539
IdHAL : brigitte-bauvois
ORCID : 0000-0002-1751-6922
IdRef : 075610108

Connectez-vous pour contacter l'auteur

Mort cellulaire et résistance aux traitements dans les hémopathies malignes

Mariana Tannoury

Function : Author

Delphine Garnier

Function : Author
PersonId : 1124032
IdHAL : garnier-delphine
ORCID : 0000-0002-5744-5612

Santos A. Susin

Function : Author
PersonId : 739916
IdHAL : santos-susin
ORCID : 0000-0002-3366-1628
IdRef : 111341566

Domains

Pharmaceutical sciences Life Sciences [q-bio]

Fichier principal

7) Tannoury et al, Review Cancers 2022.pdf (2.05 Mo)

Origin	Files produced by the author(s)

Brigitte Bauvois : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03931267

Submitted on : Monday, January 9, 2023-4:09:09 PM

Last modification on : Friday, April 19, 2024-4:18:59 PM

Long-term archiving on: Monday, April 10, 2023-7:20:59 PM

Dates and versions

hal-03931267 , version 1 (09-01-2023)

Identifiers

HAL Id : hal-03931267 , version 1

Cite

B. Bauvois, Mariana Tannoury, Delphine Garnier, Santos A. Susin. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?. Cancers, 2022. ⟨hal-03931267⟩

Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share